Acute and chronic arsenic toxicity

Arsenic toxicity is a global health problem affecting many millions of people. Contamination is caused by arsenic from natural geological sources leaching into aquifers, contaminating drinking water and may also occur from mining and other industrial processes. Arsenic is present as a contaminant in many traditional remedies. Arsenic trioxide is now used to treat acute promyelocytic leukaemia. Absorption occurs predominantly from ingestion from the small intestine, though minimal absorption occurs from skin contact and inhalation. Arsenic exerts its toxicity by inactivating up to 200 enzymes, especially those involved in cellular energy pathways and DNA synthesis and repair. Acute arsenic poisoning is associated initially with nausea, vomiting, abdominal pain, and severe diarrhoea. Encephalopathy and peripheral neuropathy are reported. Chronic arsenic toxicity results in multisystem disease. Arsenic is a well documented human carcinogen affecting numerous organs. There are no evidence based treatment regimens to treat chronic arsenic poisoning but antioxidants have been advocated, though benefit is not proven. The focus of management is to reduce arsenic ingestion from drinking water and there is increasing emphasis on using alternative supplies of water.

[1]  A. Smith,et al.  Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. , 1998, International journal of epidemiology.

[2]  T. Gebel Confounding variables in the environmental toxicology of arsenic. , 2000, Toxicology.

[3]  A. Poklis,et al.  Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller. , 1989, Journal of analytical toxicology.

[4]  C. Morris,et al.  Arsenic and mercury intoxication due to Indian ethnic remedies. , 1993, BMJ.

[5]  T. Krishnamoorthy,et al.  Arsenic intake by the adult population in Bombay city. , 1997, The Science of the total environment.

[6]  N. Benowitz,et al.  Toxicologic causes of acute abdominal disorders. , 1989, Emergency medicine clinics of North America.

[7]  D. R. Lewis,et al.  Drinking water arsenic in Utah: A cohort mortality study. , 1999, Environmental health perspectives.

[8]  Dau Pc,et al.  Chronic arsenic poisoning masquerading as Landry-Guillain-Barré syndrome. , 1992 .

[9]  J. P. Campbell,et al.  Acute arsenic intoxication. , 1989, American family physician.

[10]  D. Green,et al.  Megaloblastic, dyserythropoietic anemia following arsenic ingestion. , 1980, Annals of clinical and laboratory science.

[11]  O. Axelson,et al.  Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. , 1978, British journal of industrial medicine.

[12]  Everall Jd,et al.  Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. , 1978 .

[13]  M. Rahman,et al.  Hypertension and arsenic exposure in Bangladesh. , 1999, Hypertension.

[14]  R. Ko Causes, epidemiology, and clinical evaluation of suspected herbal poisoning. , 1999, Journal of toxicology. Clinical toxicology.

[15]  G. B. Miller,et al.  Outbreak of fatal arsenic poisoning caused by contaminated drinking water. , 1984, Archives of environmental health.

[16]  M. H. Smith,et al.  Arsenic-induced skin lesions among Atacameño people in Northern Chile despite good nutrition and centuries of exposure. , 2000, Environmental health perspectives.

[17]  C. Drage,et al.  Acute respiratory failure following severe arsenic poisoning. , 1979, Chest.

[18]  R. Fincher,et al.  Long-term survival in acute arsenic encephalopathy. Follow-up using newer measures of electrophysiologic parameters. , 1987, The American journal of medicine.

[19]  J. Borgoño,et al.  Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. , 1977, Environmental health perspectives.

[20]  J. Cobo,et al.  Oxidative stress, mitochondrial respiration, and glycemic control: clues from chronic supplementation with Cr3+ or As3+ to male Wistar rats. , 1997, Nutrition.

[21]  Wei Tang,et al.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[22]  J. Everall,et al.  Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. , 1978, Bulletin du cancer.

[23]  M. Zaw,et al.  Arsenic removal from water using advanced oxidation processes. , 2002, Toxicology letters.

[24]  J. Bayle,et al.  Intoxication suraiguë à l'arsenic , 1991 .

[25]  M. Bleecker,et al.  Acute encephalopathy due to occupational exposure to arsenic. , 1986, British journal of industrial medicine.

[26]  S. Lipsitz,et al.  Arsenic in Drinking Water and Incidence of Urinary Cancers , 1997, Epidemiology.

[27]  M. Rahman,et al.  Diabetes mellitus associated with arsenic exposure in Bangladesh. , 1998, American journal of epidemiology.

[28]  R. Stanley,et al.  Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). , 1975, Gastroenterology.

[29]  S. Hall,et al.  Clinical observations and medical outcome in 149 cases of arsenate ant killer ingestion. , 1993, Journal of toxicology. Clinical toxicology.

[30]  L. McWilliam,et al.  A Field Based Evaluation of Household Arsenic Removal Technologies for the Treatment of Drinking Water , 2002, Environmental technology.

[31]  D. Chakraborti,et al.  Chronic Arsenic Toxicity in Bangladesh and West Bengal, India—A Review and Commentary , 2001, Journal of toxicology. Clinical toxicology.

[32]  A. Poklis,et al.  Arsenic poisoning: acute or chronic? Suicide or murder? , 1990, The American journal of forensic medicine and pathology.

[33]  E. Ebert,et al.  Maldigestion and malabsorption. , 2001, Disease-a-month : DM.

[34]  W. Morton,et al.  Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? , 1989, American journal of industrial medicine.

[35]  G. Quatrehomme,et al.  Acute arsenic intoxication: forensic and toxicologic aspects (an observation). , 1992, Journal of forensic sciences.

[36]  J. Cassar,et al.  Herbal Medicine as a Cause of Combined Lead and Arsenic Poisoning , 1990, Human & experimental toxicology.

[37]  V. Lallemand-Breitenbach,et al.  How acute promyelocytic leukaemia revived arsenic , 2002, Nature Reviews Cancer.

[38]  A. Auvinen,et al.  Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. , 1999, Environmental health perspectives.

[39]  G. Elfenbein,et al.  Nasopharyngeal cardcinoma associated with long-term arsenic ingestion. , 1978, Archives of dermatology.

[40]  A. Páldy,et al.  Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water , 1998, Environmental and molecular mutagenesis.

[41]  Prosun Bhattacharya,et al.  Arsenic in groundwater in the Bengal Delta Plain: slow poisoning in Bangladesh , 2001 .

[42]  E. Zafrani,et al.  Hepatic angiosarcoma. , 1983, Journal of computer assisted tomography.

[43]  D. Thompson,et al.  A chemical hypothesis for arsenic methylation in mammals. , 1993, Chemico-biological interactions.

[44]  S. Silver,et al.  Bacterial transformations of and resistances to heavy metals. , 1984, Basic life sciences.

[45]  H. Aposhian Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. , 1997, Annual review of pharmacology and toxicology.

[46]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[47]  K. Ahmed,et al.  Arsenic poisoning of Bangladesh groundwater , 1998, Nature.

[48]  J. C. Paterson,et al.  Arsenical Encephalopathy , 1945, British medical journal.

[49]  A. From,et al.  Arsenic-induced atypical ventricular tachycardia. , 1980, The New England journal of medicine.

[50]  R. Hood,et al.  Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice. , 1984, Toxicology and applied pharmacology.

[51]  M. Vahter,et al.  Exposure to inorganic arsenic metabolites during early human development. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  J. Edmonds,et al.  Transformations of arsenic in the marine environment , 1987, Experientia.

[53]  H. Lien,et al.  Merkel cell carcinoma and chronic arsenicism. , 1999, Journal of the American Academy of Dermatology.

[54]  Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. , 1977 .

[55]  W. Regelson,et al.  Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by fowler's solution , 1968, Cancer.

[56]  P. Pandolfi,et al.  Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. , 1998, The New England journal of medicine.

[57]  J. Couch,et al.  Prolonged encephalopathy with arsenic poisoning , 1978, Neurology.

[58]  E. Ong,et al.  Determination of arsenic in traditional Chinese medicine by microwave digestion with flow injection-inductively coupled plasma mass spectrometry (FI-ICP-MS). , 1999, Journal of AOAC International.

[59]  C. Chen,et al.  Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. , 1997, Stroke.

[60]  D. Chakraborti,et al.  Groundwater arsenic contamination in Bangladesh and West Bengal, India. , 2000, Environmental health perspectives.

[61]  S. Kaye Arsenic poisoning. , 1959, Virginia medical monthly.

[62]  A. Smith,et al.  Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. , 1993, Environmental research.

[63]  Teo Sk,et al.  The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. , 1998 .

[64]  F. Nevens,et al.  Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. , 1994, Gastroenterology.

[65]  B. Fowler,et al.  Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.

[66]  T. Yuan,et al.  ARSENIC REMOVAL FROM HOUSEHOLD DRINKING WATER BY ADSORPTION , 2002, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[67]  J. Matschullat Arsenic in the geosphere--a review. , 2000, The Science of the total environment.

[68]  A. Santra,et al.  Chronic arsenic toxicity in west Bengal--the worst calamity in the world. , 1998, Journal of the Indian Medical Association.

[69]  D. Lison,et al.  Assessment of exposure to inorganic arsenic, a human carcinogen, due to the consumption of seafood , 1996, Archives of Toxicology.

[70]  J. Quinn,et al.  Arsenic Trioxide in the Treatment of a Patient with Multiply Recurrent, ATRA‐Resistant Promyelocytic Leukemia: A Case Report , 1998, Journal of pediatric hematology/oncology.

[71]  A. Lee-Feldstein A comparison of several measures of exposure to arsenic. Matched case-control study of copper smelter employees. , 1989, American journal of epidemiology.

[72]  L. Fanton,et al.  Arsenic speciation in human organs following fatal arsenic trioxide poisoning--a case report. , 1999, Clinical chemistry.

[73]  J. Shen,et al.  Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro. , 1999, International journal of molecular medicine.

[74]  T. Hung,et al.  Estimation of Target Hazard Quotients and Potential Health Risks for Metals by Consumption of Seafood in Taiwan , 1998, Archives of environmental contamination and toxicology.

[75]  A. Santra,et al.  Hepatic manifestations in chronic arsenic toxicity. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[76]  A H Smith,et al.  Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. , 1998, International journal of epidemiology.

[77]  F. McLellan Arsenic contamination affects millions in Bangladesh , 2002, The Lancet.

[78]  G. Kroemer,et al.  Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death , 1999, Cell Death and Differentiation.

[79]  D. Clark Genetically determined variability in acetylation and oxidation. Therapeutic implications. , 1985, Drugs.

[80]  E. Estey,et al.  Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia , 2003, Cancer.

[81]  P. Fenaux,et al.  Treatment of acute promyelocytic leukaemia. , 2001, Best practice & research. Clinical haematology.

[82]  P. Enterline,et al.  Mortality experience in relation to a measured arsenic trioxide exposure , 1977, Environmental health perspectives.

[83]  Campbell Jp,et al.  Acute arsenic intoxication. , 1989 .

[84]  A. Smith,et al.  Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. , 2000, International journal of epidemiology.

[85]  M. Vahter,et al.  Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. , 1998, Environmental health perspectives.

[86]  Y. Ko,et al.  Mortality for certain diseases in areas with high levels of arsenic in drinking water. , 1999, Archives of environmental health.

[87]  S. Tamaki,et al.  Environmental biochemistry of arsenic. , 1992, Reviews of environmental contamination and toxicology.

[88]  Y. Hsueh,et al.  Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. , 1998, Atherosclerosis.

[89]  C. Goh,et al.  Cutaneous manifestations of chronic arsenicism: review of seventeen cases. , 1998, Journal of the American Academy of Dermatology.

[90]  R. Williams,et al.  Arsine toxicity aboard the Asiafreighter. , 1975, British medical journal.

[91]  M. Berry,et al.  Population-based dietary intakes and tap water concentrations for selected elements in the EPA Region V National Human Exposure Assessment Survey (NHEXAS) , 1999, Journal of Exposure Analysis and Environmental Epidemiology.

[92]  M. V. Aguilar,et al.  Mechanisms of absorption of As2O5 from rat small intestine: the effect of different parameters. , 1997, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.